<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.peertechzpublications.org/assets/xsl/oaitohtml.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
										<responseDate>2026-04-29T14:33:55Z</responseDate>
										<request verb="GetRecord" metadataPrefix="oai_dc" identifier="oai:www.peertechzpublications.org:10.17352/amm.000024">https://www.peertechzpublications.org/oai-pmh</request><GetRecord><record>
								<header>
									<identifier>oai:www.peertechzpublications.org:10.17352/amm.000024</identifier>
									<datestamp>2021-01-06</datestamp>
									<setSpec>PTZ.AMM:VOL5</setSpec>
								</header>
								<metadata>
									<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
										<dc:title>
										Nutritional intervention for cancer sarcopenia
										</dc:title><dc:creator>Takuya Mori</dc:creator><dc:creator> Akira Kido</dc:creator><dc:creator> Isao Kawahara</dc:creator><dc:creator> Shota Nuaga</dc:creator><dc:creator> Yoshihiro Miyagawa</dc:creator><dc:creator> Kei Goto</dc:creator><dc:creator> Shiori Mori</dc:creator><dc:creator> Shingo Kishi</dc:creator><dc:creator> Kiyomu Fujii</dc:creator><dc:creator> Rina Fujiwara-Tani</dc:creator><dc:creator>Hiroki Kuniyasu</dc:creator><dc:description>&lt;p&gt;Most patients with advanced cancer develop skeletal muscle atrophy called sarcopenia, which reduces treatment tolerance and social activity and worsens the prognosis. Glucose suppresses skeletal muscle atrophy in cancer-bearing mice, while promoting cancer growth. In contrast, medium-chain fatty acids reduce skeletal muscle atrophy and suppress cancer growth. Simultaneous administration of glucose and medium-chain fatty acids suppresses skeletal muscle atrophy and eliminates the tumor growth seen in glucose. Based on these findings, dietary intervention using a combination of glucose and medium-chain fatty acids is expected to be effective in suppressing sarcopenia in cancer patients.&lt;/p&gt;</dc:description>
										<dc:publisher>Annals of Musculoskeletal Medicine - Peertechz Publications</dc:publisher>
										<dc:date>2021-01-06</dc:date>
										<dc:type>Research Article</dc:type>
										<dc:identifier>https://doi.org/10.17352/amm.000024</dc:identifier>
										<dc:language>en</dc:language>
										<dc:rights>Copyright © Takuya Mori et al.</dc:rights>
									</oai_dc:dc>
								</metadata>
							</record></GetRecord>
						</OAI-PMH>
